DSP-Visulex (dexamethasone sodium phosphate ophthalmic) / Aciont  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DSP-Visulex (dexamethasone sodium phosphate ophthalmic) / Aciont
NCT02309385: Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Completed
1/2
44
US
8% Dexamethasone Sodium Phosphate - Visulex, 8% DSP- Visulex, 15% Dexamethasone Sodium Phosphate - Visulex, Prednisolone Acetate (1%) Eye Drops, Pred Forte
Aciont Inc, National Eye Institute (NEI)
Non-Infectious Anterior Uveitis
03/17
03/17

Download Options